EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease

Tatiana Suárez-Cortés iD, Itxaso Herrera

Journal of Clinical Medicine · 11.06.2025 · 14 (12) · 4147

DOI: 10.3390/jcm14124147 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.06.2025. Verfasst von Tatiana Suárez-Cortés und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research, Development and Innovation Department (R&D+I Department), FAES Farma, Av. Autonomía 10, 48940 Leioa, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faes Farma S.A..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED) is a common, multifactorial disorder of the ocular surface. Although DED can affect individuals at any age, its prevalence, clinical manifestations, underlying mechanisms, and optimal management strategies differ considerably across the lifespan. In children, symptoms are frequently associated with atopy and allergic disorders and environmental factors, whereas in young adults, digital device usage and contact lens wear are the predominant contributors. In older adults, systemic diseases and polypharmacy significantly elevate the risk of DED. Across all age groups, tear film instability, decreased tear production, and chronic inflammation are central pathogenic features. Key tear biomarkers, such as pro-inflammatory cytokines, have been widely linked to disease development. Cathepsin S and tumor necrosis factor-alpha have recently been implicated in age-related DED. A nuanced understanding of these age-related differences is crucial for improving diagnostic accuracy and tailoring interventions to specific patient populations. This review synthesizes current evidence on DED across age groups, focusing on prevalence, risk factors, pathophysiology, molecular mechanisms, coexisting conditions, biomarkers, and treatment options. Finally, it highlights critical unmet clinical needs in the management of age-related DED.

Schlagwörter

Stichwörter der Autor:innen

age targetedbiomarkerschildrendry eye diseaseelderlyocular surfacetearstreatmentyoung adults

Autor:innen und Institutionen

  • Research, Development and Innovation Department (R&D+I Department), FAES Farma, Av. Autonomía 10, 48940 Leioa, Spain.
  • Neuro-Ophthalmology Department and Pediatric Ophthalmology, Miranza Clínica Begoña, 48006 Bilbao, Spain.

ORCID-Profile: Tatiana Suárez-Cortés

Förderung

  • Faes Farma S.A.

Zitieren

APA

Suárez-Cortés, T., & Herrera, I. (2025). Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease. Journal of Clinical Medicine, 14(12), 4147. https://doi.org/10.3390/jcm14124147

Vancouver

Suárez-Cortés T, Herrera I. Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease. Journal of Clinical Medicine. 2025;14(12):4147. doi:10.3390/jcm14124147

BibTeX
@article{SurezCorts2025,
  author = {Suárez-Cortés, Tatiana and Herrera, Itxaso},
  title = {Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {4147},
  doi = {10.3390/jcm14124147}
}
Kostenlos starten →